BioCentury
ARTICLE | Clinical News

Lumigan bimatoprost: Phase II data

May 6, 2013 7:00 AM UTC

Allergan disclosed on its 1Q13 earnings call that data from a pair of double-blind, U.S. and German Phase II trials in about 300 men and 300 women with alopecia, respectively, showed that bimatoprost ...